ASRS
TGTX icon

Arizona State Retirement System’s TG Therapeutics TGTX Stock Holding History

Arizona State Retirement System’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.24M Sell
40,758
-669
-2% -$27.4K 0.01% 756
2026
Q1 		$1.38M Sell
41,427
-497
-1% -$14.8K 0.01% 920
2025
Q4 		$1.25M Sell
41,924
-2,720
-6% -$88.8K 0.01% 993
2025
Q3 		$1.61M Buy
44,644
+1,108
+3% +$36.5K 0.01% 896
2025
Q2 		$1.57M Buy
43,536
+1,161
+3% +$43.2K 0.01% 877
2025
Q1 		$1.67M Sell
42,375
-264
-0.6% -$8.88K 0.01% 809
2024
Q4 		$1.28M Buy
42,639
+364
+0.9% +$10.4K 0.01% 976
2024
Q3 		$989K Buy
42,275
+1,206
+3% +$26.3K 0.01% 1104
2024
Q2 		$731K Buy
41,069
+1,539
+4% +$24.6K ﹤0.01% 1217
2024
Q1 		$601K Sell
39,530
-565
-1% -$9K ﹤0.01% 1329
2023
Q4 		$685K Sell
40,095
-316
-0.8% -$3.67K 0.01% 1271
2023
Q3 		$338K Buy
40,411
+1,356
+3% +$18.9K ﹤0.01% 1601
2023
Q2 		$970K Sell
39,055
-952
-2% -$24.6K 0.01% 1030
2023
Q1 		$602K Buy
40,007
+1,064
+3% +$16.2K 0.01% 1306
2022
Q4 		$461K Buy
38,943
+1,655
+4% +$12K ﹤0.01% 1420
2022
Q3 		$221K Buy
37,288
+487
+1% +$3.19K ﹤0.01% 1824
2022
Q2 		$156K Buy
36,801
+3,957
+12% +$24.7K ﹤0.01% 2010
2022
Q1 		$312K Buy
32,844
+168
+0.5% +$1.94K ﹤0.01% 1775
2021
Q4 		$621K Sell
32,676
-79
-0.2% -$2.05K ﹤0.01% 1401
2021
Q3 		$1.09M Buy
32,755
+913
+3% +$28.2K 0.01% 1035
2021
Q2 		$1.24M Buy
31,842
+1,220
+4% +$47.9K 0.01% 983
2021
Q1 		$1.48M Buy
30,622
+1,239
+4% +$59.5K 0.01% 882
2020
Q4 		$1.53M Sell
29,383
-433
-1% -$14.6K 0.01% 806
2020
Q3 		$798K Buy
29,816
+12,042
+68% +$277K 0.01% 1036
2020
Q2 		$346K Sell
17,774
-3,262
-16% -$52.5K ﹤0.01% 1335
2020
Q1 		$207K Buy
+21,036
New +$266K ﹤0.01% 1497

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Arizona State Retirement System's TGTX Position: Q2 2026 in Review

Arizona State Retirement System reduced its TG Therapeutics (TGTX) stake by 1.6% in Q2 2026, selling an estimated $27.4K and leaving 40,758 shares worth $2.24M. The position accounts for 0.01% of the portfolio, ranked #756.

Arizona State Retirement System first reported a position in TGTX in Q1 2020 and has held it in 26 quarters since. 428 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Arizona State Retirement System held 40,758 shares of TG Therapeutics worth $2.24M as of Q2 2026.
  • Arizona State Retirement System sold 669 TG Therapeutics shares in Q2 2026, an estimated $27.4K.
  • TG Therapeutics made up 0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #756 holding.
  • Arizona State Retirement System first reported a position in TG Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • 428 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.